LABORATORY CORPORATION OF AMERICA HOLDINGS Funds and ETFs Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.7 USD | +0.74% |
|
+3.15% | -8.63% |
ETFs positioned on Laboratory Corporation of America Holdings
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.97% | 0 M€ | +9.27% | ||
| 1.95% | 0 M€ | +4.88% | ||
| 0.82% | 0 M€ | +7.69% | - | |
| 0.43% | 0 M€ | +8.67% | ||
| 0.39% | 92 M€ | +0.06% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.23% | 3 M€ | +7.32% | - | |
| 0.23% | 1 M€ | +11.94% | - | |
| 0.23% | 13 M€ | -.--% | - | |
| 0.19% | 5 M€ | -72.95% | - | |
| 0.19% | 0 M€ | +9.42% | ||
| 0.18% | 2 M€ | +20.44% | ||
| 0.15% | 0 M€ | +5.63% | - | |
| 0.15% | 0 M€ | +1.41% | - | |
| 0.15% | 0 M€ | +5.63% | - | |
| 0.14% | 469 M€ | -2.05% | ||
| 0.14% | 3,859 M€ | +18.82% | ||
| 0.12% | 0 M€ | +12.85% | ||
| 0.11% | 4,592 M€ | +11.18% | ||
| 0.11% | 414 M€ | +11.90% | - | |
| 0.11% | 1,006 M€ | -.--% | ||
| 0.11% | 29 M€ | -.--% | - | |
| 0.11% | 322 M€ | +13.88% | ||
| 0.10% | 219 M€ | +17.17% | - | |
| 0.10% | 1,448 M€ | -.--% | - | |
| 0.10% | 0 M€ | +8.70% | ||
| 0.10% | 0 M€ | +4.60% | - | |
| 0.09% | 330 M€ | -.--% |
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
14/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
207.7
USD
Average target price
239.6
USD
Spread / Average Target
+15.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.63% | 17.51B | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.65% | 29.06B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.23% | 12.42B | |
| +6.43% | 12.77B | |
| +31.27% | 12.06B |
- Stock Market
- Equities
- LH Stock
- Funds and ETFs Laboratory Corporation of America Holdings